RO-5256390
Identifiers
  • (S)-4-((S)-2-phenyl-butyl)-4,5-dihydro-oxazol-2-ylamine
PubChem CID
ChemSpider
Chemical and physical data
FormulaC13H18N2O
Molar mass218.300 g·mol−1
3D model (JSmol)
  • NC1=N[C@@H](C[C@@H](C2=CC=CC=C2)CC)CO1
  • InChI=1S/C13H18N2O/c1-2-10(11-6-4-3-5-7-11)8-12-9-16-13(14)15-12/h3-7,10,12H,2,8-9H2,1H3,(H2,14,15)/t10-,12-/m0/s1
  • Key:IXDKFUBXESWHSL-JQWIXIFHSA-N

RO-5256390 is a drug developed by Hoffmann-La Roche which acts as an agonist for the trace amine associated receptor 1. It is shown to block compulsive and binge-like eating behavior in rats.[1]

Reference section

edit
  1. ^ Ferragud, Antonio; Howell, Adam D.; Moore, Catherine F.; Ta, Tina L.; Hoener, Marius C.; Sabino, Valentina; Cottone, Pietro (2017-06). "The Trace Amine-Associated Receptor 1 Agonist RO5256390 Blocks Compulsive, Binge-like Eating in Rats". Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology. 42 (7): 1458–1470. doi:10.1038/npp.2016.233. ISSN 1740-634X. PMC 5436108. PMID 27711047. {{cite journal}}: Check date values in: |date= (help)